Industry Bodies Urge GMO Exemption For Advanced Therapies In EU
CRISPR/Cas9 Genome Editing Tool Could Be Affected
Executive Summary
ATMPs should be treated like COVID-19 products when it comes to the EU rules on genetically modified organisms, say ARM, EFPIA and EuropaBio.